The ADC landscape is evolving rapidly, creating new opportunities to improve targeting, enhance efficacy, and bring innovative therapies to patients. At World ADC San Diego 2026, Lonza will showcase how our integrated bioconjugates and ADC capabilities help innovators navigate complexity, reduce development risk, and accelerate their path to clinical and commercial success.

Meet with our experts to discuss your specific program challenges, learn about the latest advances in ADC development and manufacturing, and explore how Lonza's end-to-end expertise can support your molecule from early development through commercialization.

We're also proud to be shortlisted for the Best ADC Platform Technology Award at the 13^th World ADC Awards for our GlycoConnect^® technology, recognizing our commitment to advancing next-generation ADC innovation.

Planning to attend World ADC?

Request a meeting with our team to discuss your ADC strategy, explore potential solutions, and discover how Lonza can help move your program forward.

Please fill in the form to request a meeting with our team